Cargando…
Long non‐coding RNA CRALA is associated with poor response to chemotherapy in primary breast cancer
BACKGROUND: Breast cancer is the most commonly diagnosed cancer in women, and has become the second leading cause of cancer death among women worldwide. Chemoresistance has become an important problem in breast cancer clinics. The identification of new mechanisms affecting chemosensitivity is of gre...
Autores principales: | Li, Yudong, Wang, Baoxiao, Lai, Hongna, Li, Shunying, You, Qiuting, Fang, Yichao, Li, Qian, Liu, Yujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668502/ https://www.ncbi.nlm.nih.gov/pubmed/28834648 http://dx.doi.org/10.1111/1759-7714.12487 |
Ejemplares similares
-
Non‐invasive analysis of tumor mutation profiles and druggable mutations by sequencing of cell free DNA of Chinese metastatic breast cancer patients
por: Li, Shunying, et al.
Publicado: (2019) -
Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Li, Shunying, et al.
Publicado: (2020) -
Global Trend in Research and Development of CDK4/6 Inhibitors for Clinical Cancer Therapy: A Bibliometric Analysis
por: Lai, Hongna, et al.
Publicado: (2021) -
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
por: Shi, Qianfeng, et al.
Publicado: (2020) -
Multiple metastases of bones and sigmoid colon after mastectomy for ductal carcinoma in situ of the breast: a case report
por: You, Qiuting, et al.
Publicado: (2019)